Continuous subcutaneous insulin infusion in patients with type 1 disease

Meetoo, D; Wong, L; Fatani, T

Abstract

Optimal blood glucose control and the restoration of physiological insulin secretion is an ongoing medical challenge. Continuous subcutaneous insulin infusion (CSII) aims to restore blood glucose levels and reduce the frequency of hypoglycaemic events. Its benefits include a better glycaemic profile compared with management involving multiple daily insulin injections and giving individuals more flexibility in their everyday lives. The advantages of insulin pumps include basal delivery consistency, adjustable basal rates and low insulin depots. However, experience with CSII indicates that candidates should be selected carefully, be well educated in how use the device and be highly motivated to improve their blood glucose control.

Citation

Meetoo, D., Wong, L., & Fatani, T. (2017). Continuous subcutaneous insulin infusion in patients with type 1 disease. British Journal of Healthcare Management, 23(7), 313-318. https://doi.org/10.12968/bjhc.2017.23.7.313

• Journal Article Type: Article
• Publication Date: Jul 2, 2017
• Deposit Date: Aug 30, 2017
• Journal: British Journal of Healthcare Management
• Print ISSN: 1358-0574
• Publisher: MA Healthcare
• Volume: 23
• Issue: 7
• Pages: 313-318
• DOI: https://doi.org/10.12968/bjhc.2017.23.7.313
• Keywords: Health Policy, Leadership and Management
• Publisher URL: http://dx.doi.org/10.12968/bjhc.2017.23.7.313
• Related Public URLs: http://www.magonlinelibrary.com/journal/bjhc